In the battle to tame the soaring cost of cancer care, projected to skyrocket past $245 billion by 2030, a new strategy emerges from the frontlines: pharmacist-led initiatives. A recent study from The US Oncology Network, representing nearly half of the Enhancing Oncology Model (EOM) providers across the nation, underscores the substantial impact pharmacists can […]
